ArticleOncotarget2017
ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis.
Kuo-Liang Chiu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it
ArticleOncotarget2017
Kuo-Liang Chiu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.